hands
Products

Targeted portfolio 

A unique portfolio of high quality and difficult-to-make pharmaceutical products fuels our targeted growth strategy. We offer high-quality, affordable generic medications that help reduce healthcare costs around the world.

A targeted portfolio
350 marketed products
Alvogen lab

Generics 

An experienced team of professionals from the generics industry has built a strong profitable base and infrastructure for our generic business in the U.S., Central Eastern Europe and the Asia Pacific region. We have teams in 35 countries and a world class regulatory team.

Product formulations manufactured and sold by Alvogen include solid oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments and injectables.

Syringes5

Biosimilars 

Alvogen’s sister company, Alvotech, is a uniquely positioned biopharmaceutical business that focuses purely on the biosimilar market with complete vertical integration from early R&D to commercial manufacturing.

Pioneering Biogenerics
Alvotech
pills-white

OTC 

Alvogen currently has an extensive OTC (over-the-counter) portfolio, offering an innovative approach to everyday health problems. Our range covers the main OTC categories: Food supplements, OTC medicines, cosmetics and medical devices.

We seek out products that offer something new to the consumer, focusing on patented technology with clinically proven efficacy, along with staple OTC products necessary in every household, such as painkillers, antihistamines and ointments. Our OTC strategy centers around comprehensive solutions based on unique target market segmentation and value added properties, such as taste, delivery form or ingredient composition.

pill large

Branded portfolio 

Alvogen is focused on the acquisition, development and commercialization of brand named Rx products through its subsidary Almatica Pharma. Almatica has a current product portfolio that includes pain, anti-infective, cardiovascular and psychiatry related therapies.

Our business model ensures competitive advantage by having broad in-house capabilities and a network of partners for enhanced speed and flexibility.

Vial line moving high-res

Commited to quality 

Manufacturing

Alvogen global operations includes five manufacturing facilities in the U.S., Romania, South-Korea and Taiwan. Capabilities include finished dosage form manufacturing including solid oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments and injectables.

Patients safety

Our goal is to ensure that the benefits and risks of a medication are continuously monitored and well-understood by regulators, healthcare providers and patients. Alvogen maintains a pharmacovigilance system, collecting information over the lifecycle of each product.

Local teams

Alvogen has commercial operations in more than 30 countries around the world, with regional hubs, manufacturing and R&D capabilities in the U.S., South Korea and Romania. Connect directly with our local temas for more information on products, business opportunities and more.

Worldwide

Worldwide offices 

Alvogen has commercial operations in 35 countries, with regional hubs, manufacturing and R&D capabilities in the U.S., South Korea and Romania.

We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. Learn more.